Andrew D. Ashe, See Remarks at Verve Therapeutics, Inc. (VERV), sold 2,681 shares at $4.15 ($11K) on 2025-04-02, disclosed to the SEC on 2025-04-03.
Open-market sale of $11k VERV by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DYAX | SELL | 2015-08-05 | $1.5M | — | Filing → |
| DYAX | SELL | 2015-03-06 | $37K | — | Filing → |
| DYAX | SELL | 2015-02-26 | $23K | — | Filing → |